MyFinsight
Home
Blog
About
US
$118,549K
Non Us
$36,631K
US
$28,190K
Non Us
$2,240K
Net loss
-$18,377K
(6.51%↑ Y/Y)
Glaucoma
$155,180K
Corneal Health
$30,430K
Loss before taxes
-$17,721K
(8.70%↑ Y/Y)
Income tax provision
$656K
(164.52%↑ Y/Y)
Net sales
$185,610K
(49.54%↑ Y/Y)
Loss from operations
-$17,267K
(23.90%↑ Y/Y)
Total non-operating
(expense) income
-$454K
(-113.84%↓ Y/Y)
Gross profit
$151,594K
(55.92%↑ Y/Y)
Interest income
$2,279K
(-11.46%↓ Y/Y)
Cost of sales
$34,016K
(26.47%↑ Y/Y)
Total operating
expenses
$168,861K
(40.82%↑ Y/Y)
Interest expense
$1,459K
(26.76%↑ Y/Y)
Other (expense)
income, net
-$1,274K
(-168.61%↓ Y/Y)
Selling, general and
administrative
$116,060K
(39.20%↑ Y/Y)
Research and development
$51,301K
(40.40%↑ Y/Y)
Acquired in-process
research and development
$1,500K
Back
Back
Income Statement
GLAUKOS Corp (GKOS)
GLAUKOS Corp (GKOS)
source: myfinsight.com